ARCHIVES

Preyer Supported For Chairmanship

This article is from The Cancer Letter archive.

Vol. 05 No. 04 | January 26, 1979

Download PDF Visit The Full Archive

Related Articles

In Brief: Parkinson To Leave CTEP For Novartis; FTC To Permit Sandoz, Ciba-Geigy Merger

January 10, 1997

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

October 26, 2012

Recompetition of $1.9 Mil. Primate Contract Approved

November 15, 1985

Anamorelin Increases Body Mass In Two Global Phase III Trials

October 31, 2014

First NCI Director To Resign Due To Presidential Election?

December 15, 2000

Siteman Wins Core Grant; Other Cancer Center News.

August 31, 2001